Chlorhexidine

What it is

Chlorhexidine (CHX) is a bis-biguanide antiseptic first synthesized in the UK in the 1950s. For over seventy years it has remained the reference compound in clinical oral care — no other topical agent matches its breadth of antimicrobial activity combined with sustained action.

In the mouth it is used as chlorhexidine digluconate, a water-soluble salt found in mouthrinses, gels, irrigating solutions, impregnated floss, and adhesive pastes. Standard concentrations in oral care products are 0.12% and 0.2%.

How it works

At physiological pH the chlorhexidine molecule carries a positive charge. Bacterial cell walls carry a negative charge. The attraction is immediate and strong.

At low concentrations (below 0.06%) CHX binds to the membrane, causes leakage of small ions like potassium, and inhibits bacterial growth — a bacteriostatic effect. At concentrations of 0.12% and above, the mechanism shifts: the molecule disrupts the membrane fully, the cytoplasm coagulates, and the cell dies. This is the bactericidal threshold.

The property that sets CHX apart from most other antiseptics is substantivity: after rinsing, it is not simply washed away. CHX adsorbs to oral mucosa, tooth surfaces, and pellicle, and continues releasing slowly for 8–12 hours after a single rinse. Alcohol and hydrogen peroxide act only at the moment of contact. CHX keeps working through your first coffee.

Chlorhexidine shows substantivity — it binds to oral tissues and maintains antimicrobial activity for up to 12 hours after a single rinse. This sustained release is the basis of its clinical efficacy. — Brookes ZLS et al., 2021, PMC7567658

The antimicrobial spectrum covers gram-positive and gram-negative bacteria, Candida species, and enveloped viruses. It is less effective against bacterial spores and acid-fast organisms.

Efficacy

The clinical evidence is solid. Systematic reviews over four decades consistently show CHX reduces plaque indices and gingival inflammation scores during short-term use.

The 0.2% concentration outperforms 0.12% against obligate anaerobes — the bacteria most implicated in periodontitis. In practice, the difference becomes clinically negligible when rinse volume is increased from 10 ml to 15 ml. Both concentrations are used in clinical protocols worldwide.

Indications with established clinical evidence:

• Gingivitis control and supportive periodontal therapy
• Post-surgical infection prevention: extractions, implants, periodontal surgery
• Management of oral candidiasis
• Root canal irrigation (combined with NaOCl protocols)
• Peri-implant mucositis management

Side effects

This is where the story of the perfect antiseptic ends.

Tooth staining. CHX binds tightly to enamel and reacts with dietary chromogens from tea, coffee, and red wine. The result is brown or grey-yellow extrinsic staining that does not respond to regular brushing. The effect is dose- and duration-dependent. It is the most common reason patients discontinue CHX mouthwash before completing a course.

Taste disturbance. Temporary alteration of taste perception is frequently reported. It resolves after stopping use, but during a course it is a real quality-of-life complaint.

Oral microbiome disruption. This is the most clinically significant concern for long-term use. Ruiz-Linares et al. (2020, PMC7083908) demonstrated that exposure to CHX shifts biofilm composition in a way that persists after the antiseptic is removed — with increased abundance of pathobiont strains.

Chlorhexidine treatment induced profound shifts in microbiota composition. Disease-associated traits increased, including higher abundance of pathobiont strains. — Ruiz-Linares M et al., npj Biofilms Microbiomes, 2020, PMC7083908

Bescos et al. (2021, PMID 34418463) found that chlorhexidine mouthwash reduces microbial diversity, suppresses nitrite-producing bacteria, and acidifies the oral environment. The nitrite pathway matters beyond the mouth: oral bacteria convert dietary nitrate to nitrite, which the body uses to produce nitric oxide — a regulator of vascular tone and systemic inflammation.

Allergic reactions. Rare but potentially severe. Anaphylaxis has been documented, most often with CHX-containing surgical irrigants and urinary catheters. Oral exposure carries a lower but non-zero risk. Any unexplained reaction during use warrants immediate discontinuation.

Antimicrobial resistance. Prolonged exposure selects for CHX-tolerant strains, particularly Staphylococcus and Pseudomonas. Cross-resistance with some antibiotics has been documented in vitro.

When to use it

Chlorhexidine is a clinical tool for specific situations — not a daily hygiene product.

Appropriate uses:

• Acute gingivitis, flare of chronic periodontitis — 2–4 week course under dental supervision
• Post-operative oral hygiene: extractions, implants, periodontal surgery — 7–14 days
• Oral candidiasis as part of a treatment protocol
• Peri-implantitis management as adjunct to mechanical debridement
• High-caries-risk patients with xerostomia — only when milder antiseptics are insufficient

Keep courses to 4 weeks or less. Reassess with a dentist before repeating.

When not to use it

Using chlorhexidine as a daily mouthwash — morning routine, every day — is a mistake. Not because it stops working. Because it works indiscriminately.

CHX does not distinguish between periodontal pathogens and the commensal bacteria that protect the mucosa, regulate local immunity, and participate in nitric oxide metabolism. Daily use eliminates both categories with equal efficiency.

For maintaining healthy oral hygiene in an otherwise healthy mouth, antiseptics with a more selective profile — cetylpyridinium chloride, zinc citrate, thymol-based essential oils — achieve the antimicrobial goal without disrupting the microbiome.

Do not use without dental prescription:

• During pregnancy (insufficient systemic safety data)
• Children under 6 years (swallowing risk, no data on microbiome development impact)
• Concurrently with other antiseptic mouthwashes
• With known hypersensitivity to biguanide compounds

QDRO position

Chlorhexidine is not in the QDRO line. That is a deliberate choice.

Our products are designed for daily use. An antiseptic with this side-effect profile — staining, microbiome disruption, taste alteration — does not belong in a daily routine. Better-targeted ingredients handle daily antibacterial support without the collateral damage.

If your dentist has prescribed a CHX course, use it. The prescription is not arbitrary. When the course ends, return to your daily care without it.